[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics (PTGX) stock surges near 52-week high amid positive clinical trial data for icotrokinra and speculation of a Johnson & Johnson acquisition. Increased social media buzz and trading volume highlight growing investor interest.
About Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc. is a biotechnology company focused on developing novel peptide-based therapeutics.
Protagonist Therapeutics, Inc uses the ticker $PTGX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Protagonist Therapeutics, Inc (PTGX) social dominance hit XXXXX which is XXX% higher than it's daily average.
- Protagonist Therapeutics, Inc (PTGX) trading volume is up XX% from the previous week.
- Protagonist Therapeutics, Inc (PTGX) social dominance is up XXXXXX% from the previous X months.
- Protagonist Therapeutics, Inc (PTGX) Galaxy Score™ is up XXXXXX% from the previous X months.
- Protagonist Therapeutics, Inc Price hit a 52-Week high of $XX for the hour
- Protagonist Therapeutics, Inc Price hit an all time of $XX for the hour
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price is near a 52-week high, driven by positive clinical trial results for icotrokinra, increased social engagement, and speculation about a potential acquisition by Johnson & Johnson, leading to higher trading volumes.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-12-12
1-Year Low: $XXXXX on 2025-02-25
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Protagonist Therapeutics, Inc (PTGX) is currently AltRank #669 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +38
X Month: XXX +65
X Months: XXX -XX
1-Year High: XXXXX on 2025-08-07
1-Year Low: XX on 2025-10-10
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +10
X Month: XX +19
X Months: XX +14
1-Year High: XX on 2025-03-10
1-Year Low: XX on 2025-08-01
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXX -XX%
X Months: XXXXXXXXXX +1,105%
X Year: XXXXXXXXXX +1,098%
1-Year High: XXXXXXXXX on 2025-11-01
1-Year Low: XXX on 2025-08-01
Engagements by network (24h): Reddit: XXX TikTok: XXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +1.80%
X Month: XXXXX -XXXX%
X Months: XXXXX +572%
X Year: XXXXX +854%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-02-04
Mentions by network (24h): Reddit: XX TikTok: XXX X: XXX YouTube: XXX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Protagonist Therapeutics, Inc (PTGX) in the last XX hours which is down XXXX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX -X%
X Month: XXX -XX%
X Months: XXXXX +993%
X Year: XXXXX +1,236%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-28
The most influential creators that mention Protagonist Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @doepke_michel | X | XXXXX | X | XXXXXX |
| @semodough | X | XXXXXX | X | XXXXX |
| @joseiltondutradetudoumpouco | X | XXXXX | X | XXXXX |
| @SteveDJacobs | X | XXXXX | X | XXXXX |
| @protocolrecordings | X | XXXXXXX | X | XXX |
| @marcelianonline | X | XXXXXXX | X | XXX |
| @Biotech2k1 | X | XXXXXX | X | XXX |
| @teologo | X | XXXXX | X | XX |
| @yodaez | X | XXXXXX | X | XX |
| @WallStSai | XX | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +5%
X Month: XX% +5%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-01-01
Most Supportive Themes:
- Positive Clinical Trial Results: (40%) Protagonist Therapeutics announced positive clinical trial results for icotrokinra, a novel peptide-based therapeutic for psoriasis.
- Increased Trading Volume and Social Activity: (35%) Significant increases in trading volume, social dominance, and engagements indicate heightened market interest and community interaction.
- Analyst Recommendations and Price Targets: (15%) Analyst ratings and price targets suggest potential upside, contributing to positive sentiment and investor confidence.
Most Critical Themes:
- Market Volatility and General Market Sentiment: (10%) Overall market sentiment is neutral, with some discussions acknowledging general market volatility.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXX% +0.0096%
X Month: XXXXX% +0.011%
X Months: XXXXX% +0.028%
X Year: XXXXX% +0.022%
1-Year High: XXXX% on 2025-03-11
1-Year Low: XXXXX% on 2025-09-07
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXXXXX% on 2025-03-17
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$5.90%
X Month: $XXXXXXXXXXXXX +$10%
X Months: $XXXXXXXXXXXXX +$67%
1-Year High: $XXXXXXXXXXXXX on 2025-12-12
1-Year Low: $XXXXXXXXXXXXX on 2025-02-27
Top Protagonist Therapeutics, Inc Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Citizens reiterated $PTGX Market Outperform/$102. $TAK $JNJ Citizens said in its note: PTGX has a big decision coming up by mid-2026 when management has to determine whether to opt out of its 50/50 U.S. profit/loss share for rusfertide with Takeda which would change PTGX's downstream economics. We assume PTGX will opt out to bring in more risk-free cash that the company can deploy to advance its earlier-stage internal pipeline"
X Link @Quantumup1 2025-12-12T12:46Z 3929 followers, 4121 engagements
"$JNJ XX billion to XXX Billion in sales by 2030"
X Link @semodough 2025-12-12T12:12Z 41.9K followers, 5342 engagements
"Beyond the Basics : TBC Prot Paladin Threat Guide. Seal-twisting vs Traditional Tanking"
YouTube Link @pojothefuego9588 2025-12-12T00:57Z XXX followers, XXX engagements
"Sorry but new Catholic convert Candace Owens attacking Stuckey for being insufficiently well versed in scripture is absolutely lolworthy No matter how many times she takes communion or any of the other sacraments she will be a complete and total prot"
X Link @FieldSpeakerZDQ 2025-12-12T00:29Z XXX followers, XXX engagements